NEW YORK (Reuters) - Biopharmaceutical company Halozyme Therapeutics Inc on Sunday said Baxter International Inc has had "manufacturing failures" in making Hylenex, a fluid absorption drug Baxter licensed from Halozyme.
Reuters: U.S., Reuters: Nation
Sun, 05/16/2010 - 8:15pm